146 related articles for article (PubMed ID: 8166142)
1. Voluntary testing for human immunodeficiency virus (HIV) in a prison population with a high prevalence of HIV.
Behrendt C; Kendig N; Dambita C; Horman J; Lawlor J; Vlahov D
Am J Epidemiol; 1994 May; 139(9):918-26. PubMed ID: 8166142
[TBL] [Abstract][Full Text] [Related]
2. HIV seroprevalence among male prison inmates in the Wisconsin Correctional System.
Hoxie NJ; Chen MH; Prieve A; Haase B; Pfister J; Vergeront JM
WMJ; 1998 May; 97(5):28-31. PubMed ID: 9617305
[TBL] [Abstract][Full Text] [Related]
3. HIV seroprevalence and the acceptance of voluntary HIV testing among newly incarcerated male prison inmates in Wisconsin.
Hoxie NJ; Vergeront JM; Frisby HR; Pfister JR; Golubjatnikov R; Davis JP
Am J Public Health; 1990 Sep; 80(9):1129-31. PubMed ID: 2382757
[TBL] [Abstract][Full Text] [Related]
4. HIV testing in prisoners: is mandatory testing mandatory?
Andrus JK; Fleming DW; Knox C; McAlister RO; Skeels MR; Conrad RE; Horan JM; Foster LR
Am J Public Health; 1989 Jul; 79(7):840-2. PubMed ID: 2735469
[TBL] [Abstract][Full Text] [Related]
5. Opt-out HIV testing in prison: informed and voluntary?
Rosen DL; Golin CE; Grodensky CA; May J; Bowling JM; DeVellis RF; White BL; Wohl DA
AIDS Care; 2015; 27(5):545-54. PubMed ID: 25506799
[TBL] [Abstract][Full Text] [Related]
6. HIV seroprevalence and reasons for refusing and accepting HIV testing.
Jones JL; Hutto P; Meyer P; Dowda H; Gamble WB; Gunn RA
Sex Transm Dis; 1993; 20(6):334-7. PubMed ID: 8108756
[TBL] [Abstract][Full Text] [Related]
7. Voluntary human immunodeficiency virus testing: acceptance levels and identification of seropositive individuals.
Lee JH; Branan L; Watkins L; Hoff GL; Bayer WL; Tegtmeier G
South Med J; 1991 Feb; 84(2):198-9. PubMed ID: 1990452
[TBL] [Abstract][Full Text] [Related]
8. Drug injection and HIV prevalence in inmates of Glenochil prison.
Gore SM; Bird AG; Burns SM; Goldberg DJ; Ross AJ; Macgregor J
BMJ; 1995 Feb; 310(6975):293-6. PubMed ID: 7866170
[TBL] [Abstract][Full Text] [Related]
9. Serosurvey of human immunodeficiency virus infection in parturients. Implications for human immunodeficiency virus testing programs of pregnant women.
Landesman S; Minkoff H; Holman S; McCalla S; Sijin O
JAMA; 1987 Nov; 258(19):2701-3. PubMed ID: 3312662
[TBL] [Abstract][Full Text] [Related]
10. HIV infection among women entering the New York State correctional system.
Smith PF; Mikl J; Truman BI; Lessner L; Lehman JS; Stevens RW; Lord EA; Broaddus RK; Morse DL
Am J Public Health; 1991 May; 81 Suppl(Suppl):35-40. PubMed ID: 2014882
[TBL] [Abstract][Full Text] [Related]
11. Seasonal and annual variation of antibody to HIV-1 among male inmates entering Maryland prisons: update.
Vlahov D; Muñoz A; Brewer F; Taylor E; Canner C; Polk BF
AIDS; 1990 Apr; 4(4):345-50. PubMed ID: 2350455
[TBL] [Abstract][Full Text] [Related]
12. Profile of HIV seropositive inmates diagnosed in Maryland's state correctional system.
Kendig N; Stough T; Austin P; Kummer L; Swetz A; Vlahov D
Public Health Rep; 1994; 109(6):756-60. PubMed ID: 7800784
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of HIV, syphilis, hepatitis B, and hepatitis C among entrants to Maryland correctional facilities.
Solomon L; Flynn C; Muck K; Vertefeuille J
J Urban Health; 2004 Mar; 81(1):25-37. PubMed ID: 15047781
[TBL] [Abstract][Full Text] [Related]
14. HIV and AIDS surveillance among inmates in Maryland prisons.
Kassira EN; Bauserman RL; Tomoyasu N; Caldeira E; Swetz A; Solomon L
J Urban Health; 2001 Jun; 78(2):256-63. PubMed ID: 11419579
[TBL] [Abstract][Full Text] [Related]
15. Comparison of HIV-antibody prevalence in patients consenting to and declining HIV-antibody testing in an STD clinic.
Hull HF; Bettinger CJ; Gallaher MM; Keller NM; Wilson J; Mertz GJ
JAMA; 1988 Aug; 260(7):935-8. PubMed ID: 3398198
[TBL] [Abstract][Full Text] [Related]
16. HIV seroprevalence and associated risk factors among male inmates at the Belize Central Prison.
Gough E; Edwards P
Rev Panam Salud Publica; 2009 Apr; 25(4):292-9. PubMed ID: 19531316
[TBL] [Abstract][Full Text] [Related]
17. Comparison of voluntary and blinded human immunodeficiency virus type 1 (HIV-1) seroprevalence surveys in a high prevalence sexually transmitted disease clinic population.
Schwarcz SK; Bolan GA; Kellogg TA; Kohn R; Lemp GF
Am J Epidemiol; 1993 Mar; 137(6):600-8. PubMed ID: 8470661
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of and risk factors for Human Immunodeficiency Virus (HIV) infection in entrants and residents of an Ethiopian prison.
Sahle ET; Amogne W; Manyazewal T; Blumenthal J; Jain S; Sun S; Young J; Ellorin E; Woldeamanuel H; Teferra L; Feleke B; Vandenberg O; Rey Z; Briggs-Hagen M; Haubrich R; McCutchan JA
PLoS One; 2023; 18(2):e0271666. PubMed ID: 36758059
[TBL] [Abstract][Full Text] [Related]
19. Implementing a routine, voluntary HIV testing program in a Massachusetts county prison.
Liddicoat RV; Zheng H; Internicola J; Werner BG; Kazianis A; Golan Y; Rubinstein EP; Freedberg KA; Walensky RP
J Urban Health; 2006 Nov; 83(6):1127-31. PubMed ID: 16897416
[TBL] [Abstract][Full Text] [Related]
20. Voluntary HIV testing in prison: do women inmates at high risk for HIV accept HIV testing?
Cotten-Oldenburg NU; Jordan BK; Martin SL; Sadowski LS
AIDS Educ Prev; 1999 Feb; 11(1):28-37. PubMed ID: 10070587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
